Mitchell S Cairo Selected Research

Mitchell S Cairo Research Topics

Disease

44	Neoplasms (Cancer) 01/2023 - 02/2003
24	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 02/2003
24	Lymphoma (Lymphomas) 01/2022 - 02/2003
22	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2023 - 03/2002
20	Leukemia 01/2023 - 10/2005
20	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 03/2002
17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 03/2002
14	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2024 - 10/2005
11	Hematologic Neoplasms (Hematological Malignancy) 09/2021 - 12/2002
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 07/2004
8	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 09/2011
8	Infections 01/2021 - 04/2003
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2015 - 09/2008
7	Tumor Lysis Syndrome 11/2023 - 12/2002
7	B-Cell Lymphoma (Lymphoma, B Cell) 08/2020 - 02/2012
6	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 12/2004
6	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2020 - 04/2010
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 12/2006
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 03/2002
5	Bronchiolitis Obliterans Syndrome 05/2015 - 04/2004
5	Thrombocytopenia (Thrombopenia) 01/2007 - 05/2002
4	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 04/2005
4	Residual Neoplasm 01/2023 - 12/2004
4	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 04/2005
4	Hyperuricemia 01/2017 - 12/2002
3	Neutropenia 10/2023 - 10/2005
3	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2010
3	Pathologic Complete Response 01/2020 - 02/2012
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2019 - 02/2010
3	Hemoglobinopathies 11/2017 - 04/2011
3	Central Nervous System Diseases (CNS Diseases) 08/2015 - 04/2007
3	Hemolysis 05/2015 - 08/2007
3	Sepsis (Septicemia) 12/2014 - 01/2002
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2014 - 02/2008
3	Skin Diseases (Skin Disease) 03/2014 - 04/2010
3	Neonatal Sepsis 01/2005 - 01/2002
2	Virus Diseases (Viral Diseases) 01/2023 - 12/2019
2	Inflammation (Inflammations) 01/2023 - 01/2021
2	Multiple Myeloma 09/2021 - 10/2008
2	Hemorrhage 01/2021 - 05/2002
2	Wounds and Injuries (Trauma) 01/2020 - 03/2014
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 04/2013
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2017 - 10/2014

Drug/Important Bio-Agent (IBA)

19	Rituximab (Mabthera)FDA Link 01/2022 - 09/2003
8	rasburicase (Elitek)FDA Link 01/2017 - 12/2002
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015 - 09/2003
7	CytokinesIBA 01/2023 - 10/2009
7	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2007
7	Etoposide (VP 16)FDA LinkGeneric 01/2015 - 01/2005
6	Monoclonal AntibodiesIBA 09/2021 - 08/2008
5	Chimeric Antigen ReceptorsIBA 10/2020 - 09/2014
5	AntigensIBA 01/2019 - 03/2002
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2018 - 04/2004
5	Methotrexate (Mexate)FDA LinkGeneric 10/2015 - 02/2007
5	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 01/2005
5	Ifosfamide FDA LinkGeneric 01/2015 - 01/2005
5	HLA Antigens (Human Leukocyte Antigens)IBA 04/2011 - 03/2002
5	Interleukin-11 (Interleukin 11)IBA 01/2007 - 05/2002
4	Uric Acid (Urate)IBA 11/2023 - 12/2002
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018 - 04/2004
4	Collagen Type VIIIBA 01/2018 - 04/2010
4	Allopurinol (Remid)FDA LinkGeneric 01/2017 - 12/2002
4	IceIBA 01/2015 - 01/2005
4	Prednisone (Sone)FDA LinkGeneric 03/2012 - 09/2003
3	Alemtuzumab (Campath)FDA Link 10/2023 - 01/2012
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 06/2011
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2022 - 02/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2002
3	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2011
3	obinutuzumabIBA 08/2020 - 12/2015
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 04/2007
3	Gemtuzumab (Mylotarg)FDA Link 04/2016 - 10/2005
3	InterleukinsIBA 12/2014 - 01/2007
3	Vincristine (Oncovin)FDA LinkGeneric 03/2012 - 04/2007
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2012 - 10/2008
3	ParaffinIBA 10/2008 - 05/2003
2	Ganciclovir (Cytovene)FDA LinkGeneric 10/2023 - 09/2007
2	KIR ReceptorsIBA 01/2023 - 10/2007
2	Peptides (Polypeptides)IBA 01/2023 - 01/2020
2	CollagenIBA 01/2023 - 01/2018
2	ibrutinibIBA 09/2022 - 01/2019
2	ruxolitinibIBA 09/2022 - 02/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2006
2	LigandsIBA 01/2021 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 11/2014
2	Granzymes (Granzyme)IBA 02/2017 - 10/2009

Therapy/Procedure

41	Therapeutics 01/2023 - 02/2003
33	Transplantation 01/2021 - 03/2002
28	Drug Therapy (Chemotherapy) 01/2022 - 04/2002
26	Stem Cell Transplantation 10/2023 - 04/2002
23	Cell Transplantation 12/2022 - 02/2008
19	Immunotherapy 01/2023 - 04/2003
15	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2004
10	Homologous Transplantation 01/2021 - 04/2006
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019 - 03/2002
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 01/2010
2	Donor Selection 01/2023 - 01/2023
2	Combination Drug Therapy (Combination Chemotherapy) 08/2020 - 03/2012
2	Aftercare (After-Treatment) 12/2017 - 11/2014
2	Length of Stay 01/2017 - 02/2008